SCOPUS 정보 검색 플랫폼

Journal of Cell Biology

Volumn 199, Issue 2, 2012, Pages 199-204

Fixing cystic fibrosis by correcting CFTR domain assembly

(2) Okiyoneda, Tsukasa a Lukacs, Gergely L a

a MCGILL UNIVERSITY (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; IVACAFTOR; LUMACAFTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CELL MEMBRANE; CODON; CYSTIC FIBROSIS; DRUG EFFICACY; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING;

CHLORIDE CHANNELS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; MUTATION; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY;

EID: 84869137686 PISSN: 00219525 EISSN: 15408140 Source Type: Journal
DOI: 10.1083/jcb.201208083 Document Type: Article

Times cited : (39)

References (58)

1
- 79551596804
- Therapeutics development for cystic fibrosis: a successful model for a multisystem genetic disease
- Ashlock, M.A., and E.R. Olson. 2011. Therapeutics development for cystic fibrosis: a successful model for a multisystem genetic disease. Annu. Rev. Med. 62:107-125. http://dx.doi.org/10.1146/annurev-med-061509-131034
- (2011) Annu. Rev. Med. , vol.62 , pp. 107-125
- Ashlock, M.A.¹ Olson, E.R.²

2
- 84863509037
- Emergent properties of proteostasis in managing cystic fibrosis
- Balch, W.E., D.M. Roth, and D.M. Hutt. 2011. Emergent properties of proteostasis in managing cystic fibrosis. Cold Spring Harb. Perspect. Biol. 3. http://dx.doi.org/10.1101/cshperspect.a004499
- (2011) Cold Spring Harb. Perspect. Biol. , vol.3
- Balch, W.E.¹ Roth, D.M.² Hutt, D.M.³

3
- 3042540232
- Pharmacological chaperones: potential treatment for conformational diseases
- Bernier, V., M. Lagacé, D.G. Bichet, and M. Bouvier. 2004. Pharmacological chaperones: potential treatment for conformational diseases. Trends Endocrinol. Metab. 15:222-228. http://dx.doi.org/10.1016/j.tem.2004.05.003
- (2004) Trends Endocrinol. Metab. , vol.15 , pp. 222-228
- Bernier, V.¹ Lagacé, M.² Bichet, D.G.³ Bouvier, M.⁴

4
- 0022423513
- Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin
- Burke, J.F., and A.E. Mogg. 1985. Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. Nucleic Acids Res. 13:6265-6272. http://dx.doi.org/10.1093/nar/13.17.6265
- (1985) Nucleic Acids Res , vol.13 , pp. 6265-6272
- Burke, J.F.¹ Mogg, A.E.²

5
- 79958088886
- Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis
- Cai, Z.W., J. Liu, H.Y. Li, and D.N. Sheppard. 2011. Targeting F508del-CFTR to develop rational new therapies for cystic fibrosis. Acta Pharmacol. Sin. 32:693-701. http://dx.doi.org/10.1038/aps.2011.71
- (2011) Acta Pharmacol. Sin. , vol.32 , pp. 693-701
- Cai, Z.W.¹ Liu, J.² Li, H.Y.³ Sheppard, D.N.⁴

6
- 0025242929
- Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
- Cheng, S.H., R.J. Gregory, J. Marshall, S. Paul, D.W. Souza, G.A. White, C.R. O'Riordan, and A.E. Smith. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:827-834. http://dx.doi.org/10.1016/0092-8674(90)90148-8
- (1990) Cell , vol.63 , pp. 827-834
- Cheng, S.H.¹ Gregory, R.J.² Marshall, J.³ Paul, S.⁴ Souza, D.W.⁵ White, G.A.⁶ O'Riordan, C.R.⁷ Smith, A.E.⁸

7
- 84855202429
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
- Clancy, J.P., S.M. Rowe, F.J. Accurso, M.L. Aitken, R.S. Amin, M.A. Ashlock, M. Ballmann, M.P. Boyle, I. Bronsveld, P.W. Campbell, et al. 2012. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 67:12-18. http://dx.doi.org/10.1136/thoraxjnl-2011-200393
- (2012) Thorax , vol.67 , pp. 12-18
- Clancy, J.P.¹ Rowe, S.M.² Accurso, F.J.³ Aitken, M.L.⁴ Amin, R.S.⁵ Ashlock, M.A.⁶ Ballmann, M.⁷ Boyle, M.P.⁸ Bronsveld, I.⁹ Campbell, P.W.¹⁰

8
- 0026325533
- Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation
- Dalemans, W., P. Barbry, G. Champigny, S. Jallat, K. Dott, D. Dreyer, R.G. Crystal, A. Pavirani, J.P. Lecocq, and M. Lazdunski. 1991. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature. 354:526-528. http://dx.doi.org/10.1038/354526a0
- (1991) Nature , vol.354 , pp. 526-528
- Dalemans, W.¹ Barbry, P.² Champigny, G.³ Jallat, S.⁴ Dott, K.⁵ Dreyer, D.⁶ Crystal, R.G.⁷ Pavirani, A.⁸ Lecocq, J.P.⁹ Lazdunski, M.¹⁰

9
- 0026781952
- Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
- Denning, G.M., M.P. Anderson, J.F. Amara, J. Marshall, A.E. Smith, and M.J. Welsh. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 358:761-764. http://dx.doi.org/10.1038/358761a0
- (1992) Nature , vol.358 , pp. 761-764
- Denning, G.M.¹ Anderson, M.P.² Amara, J.F.³ Marshall, J.⁴ Smith, A.E.⁵ Welsh, M.J.⁶

10
- 79957455592
- Unravelling the folding and stability of an ABC (ATP-binding cassette) transporter
- DiBartolo, N., and P.J. Booth. 2011. Unravelling the folding and stability of an ABC (ATP-binding cassette) transporter. Biochem. Soc. Trans. 39: 751-760.
- (2011) Biochem. Soc. Trans. , vol.39 , pp. 751-760
- DiBartolo, N.¹ Booth, P.J.²

11
- 65249147217
- Cooperative assembly and misfolding of CFTR domains in vivo
- Du, K., and G.L. Lukacs. 2009. Cooperative assembly and misfolding of CFTR domains in vivo. Mol. Biol. Cell. 20:1903-1915. http://dx.doi.org/10.1091/mbc.E08-09-0950
- (2009) Mol. Biol. Cell. , vol.20 , pp. 1903-1915
- Du, K.¹ Lukacs, G.L.²

12
- 11444266284
- The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR
- Du, K., M. Sharma, and G.L. Lukacs. 2005. The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR. Nat. Struct. Mol. Biol. 12:17-25. http://dx.doi.org/10.1038/nsmb882
- (2005) Nat. Struct. Mol. Biol. , vol.12 , pp. 17-25
- Du, K.¹ Sharma, M.² Lukacs, G.L.³

13
- 78651236672
- - channels
- - channels. Physiology (Bethesda). 25:357-363. http://dx.doi.org/10.1152/physiol.00030.2010
- (2010) Physiology (Bethesda) , vol.25 , pp. 357-363
- Ferrera, L.¹ Caputo, A.² Galietta, L.J.³

14
- 33645307384
- The ABC protein turned chloride channel whose failure causes cystic fibrosis
- Gadsby, D.C., P. Vergani, and L. Csanády. 2006. The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature. 440:477-483. http://dx.doi.org/10.1038/nature04712
- (2006) Nature , vol.440 , pp. 477-483
- Gadsby, D.C.¹ Vergani, P.² Csanády, L.³

15
- 0035933577
- Green fluorescent protein-based halide indicators with improved chloride and iodide affinities
- Galietta, L.J., P.M. Haggie, and A.S. Verkman. 2001. Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett. 499:220-224. http://dx.doi.org/10.1016/S0014-5793 (01)02561-3
- (2001) FEBS Lett , vol.499 , pp. 220-224
- Galietta, L.J.¹ Haggie, P.M.² Verkman, A.S.³

16
- 60149095412
- Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy
- UK Cystic Fibrosis Gene Therapy Consortium
- Griesenbach, U., and E.W. Alton. UK Cystic Fibrosis Gene Therapy Consortium. 2009. Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. Adv. Drug Deliv. Rev. 61:128-139. http://dx.doi.org/10.1016/j.addr.2008.09.010
- (2009) Adv. Drug Deliv. Rev. , vol.61 , pp. 128-139
- Griesenbach, U.¹ Alton, E.W.²

17
- 79551678082
- The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to facilitate RMA1 E3-dependent degradation of nascent CFTRDeltaF508
- Grove, D.E., C.Y. Fan, H.Y. Ren, and D.M. Cyr. 2011. The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to facilitate RMA1 E3-dependent degradation of nascent CFTRDeltaF508. Mol. Biol. Cell. 22:301-314. http://dx.doi.org/10.1091/mbc.E10-09-0760
- (2011) Mol. Biol. Cell. , vol.22 , pp. 301-314
- Grove, D.E.¹ Fan, C.Y.² Ren, H.Y.³ Cyr, D.M.⁴

18
- 33947501381
- The folding and evolution of multidomain proteins
- Han, J.H., S. Batey, A.A. Nickson, S.A. Teichmann, and J. Clarke. 2007. The folding and evolution of multidomain proteins. Nat. Rev. Mol. Cell Biol. 8:319-330. http://dx.doi.org/10.1038/nrm2144
- (2007) Nat. Rev. Mol. Cell Biol. , vol.8 , pp. 319-330
- Han, J.H.¹ Batey, S.² Nickson, A.A.³ Teichmann, S.A.⁴ Clarke, J.⁵

19
- 55549094466
- Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating
- He, L., A.A. Aleksandrov, A.W. Serohijos, T. Hegedus, L.A. Aleksandrov, L. Cui, N.V. Dokholyan, and J.R. Riordan. 2008. Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J. Biol. Chem. 283:26383-26390. http://dx.doi.org/10.1074/jbc.M803894200
- (2008) J. Biol. Chem. , vol.283 , pp. 26383-26390
- He, L.¹ Aleksandrov, A.A.² Serohijos, A.W.³ Hegedus, T.⁴ Aleksandrov, L.A.⁵ Cui, L.⁶ Dokholyan, N.V.⁷ Riordan, J.R.⁸

20
- 77954983869
- Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR
- He, L., L.A. Aleksandrov, L. Cui, T.J. Jensen, K.L. Nesbitt, and J.R. Riordan. 2010. Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR. FASEB J. 24:3103-3112. http://dx.doi.org/10.1096/fj.09-141788
- (2010) FASEB J , vol.24 , pp. 3103-3112
- He, L.¹ Aleksandrov, L.A.² Cui, L.³ Jensen, T.J.⁴ Nesbitt, K.L.⁵ Riordan, J.R.⁶

21
- 78651264296
- Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening
- Kalid, O., M. Mense, S. Fischman, A. Shitrit, H. Bihler, E. Ben-Zeev, N. Schutz, N. Pedemonte, P.J. Thomas, R.J. Bridges, et al. 2010. Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening. J. Comput. Aided Mol. Des. 24:971-991. http://dx.doi.org/10.1007/s10822-010-9390-0
- (2010) J. Comput. Aided Mol. Des. , vol.24 , pp. 971-991
- Kalid, O.¹ Mense, M.² Fischman, S.³ Shitrit, A.⁴ Bihler, H.⁵ Ben-Zeev, E.⁶ Schutz, N.⁷ Pedemonte, N.⁸ Thomas, P.J.⁹ Bridges, R.J.¹⁰

22
- 50149098401
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- Kerem, E., S. Hirawat, S. Armoni, Y. Yaakov, D. Shoseyov, M. Cohen, M. Nissim-Rafinia, H. Blau, J. Rivlin, M. Aviram, et al. 2008. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet. 372:719-727. http://dx.doi.org/10.1016/S0140-6736(08)61168-X
- (2008) Lancet , vol.372 , pp. 719-727
- Kerem, E.¹ Hirawat, S.² Armoni, S.³ Yaakov, Y.⁴ Shoseyov, D.⁵ Cohen, M.⁶ Nissim-Rafinia, M.⁷ Blau, H.⁸ Rivlin, J.⁹ Aviram, M.¹⁰

23
- 77955025743
- The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface
- Loo, T.W., M.C. Bartlett, and D.M. Clarke. 2010. The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface. Biochemistry. 49:6352-6357. http://dx.doi.org/10.1021/bi100807h
- (2010) Biochemistry , vol.49 , pp. 6352-6357
- Loo, T.W.¹ Bartlett, M.C.² Clarke, D.M.³

24
- 0027380236
- The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane Determination of functional half-lives on transfected cells
- Lukacs, G.L., X.B. Chang, C. Bear, N. Kartner, A. Mohamed, J.R. Riordan, and S. Grinstein. 1993. The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J. Biol. Chem. 268:21592-21598.
- (1993) J. Biol. Chem. , vol.268 , pp. 21592-21598
- Lukacs, G.L.¹ Chang, X.B.² Bear, C.³ Kartner, N.⁴ Mohamed, A.⁵ Riordan, J.R.⁶ Grinstein, S.⁷

25
- 84862909346
- Requirements forefficient correction of δF508 CFTR revealed by analyses of evolved sequences
- Mendoza, J.L., A. Schmidt, Q. Li, E. Nuvaga, T. Barrett, R.J. Bridges, A.P. Feranchak, C.A. Brautigam, and P.J. Thomas. 2012. Requirements forefficient correction of δF508 CFTR revealed by analyses of evolved sequences. Cell. 148:164-174. http://dx.doi.org/10.1016/j.cell.2011.11.023
- (2012) Cell , vol.148 , pp. 164-174
- Mendoza, J.L.¹ Schmidt, A.² Li, Q.³ Nuvaga, E.⁴ Barrett, T.⁵ Bridges, R.J.⁶ Feranchak, A.P.⁷ Brautigam, C.A.⁸ Thomas, P.J.⁹

26
- 50249090046
- Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces
- Mornon, J.P., P. Lehn, and I. Callebaut. 2008. Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces. Cell. Mol. Life Sci. 65:2594-2612. http://dx.doi.org/10.1007/s00018-008-8249-1
- (2008) Cell. Mol. Life Sci. , vol.65 , pp. 2594-2612
- Mornon, J.P.¹ Lehn, P.² Callebaut, I.³

27
- 77955607650
- Peripheral protein quality control removes unfolded CFTR from the plasma membrane
- Okiyoneda, T., H. Barrière, M. Bagdány, W.M. Rabeh, K. Du, J. Höhfeld, J.C. Young, and G.L. Lukacs. 2010. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science. 329:805-810. http://dx.doi.org/10.1126/science.1191542
- (2010) Science , vol.329 , pp. 805-810
- Okiyoneda, T.¹ Barrière, H.² Bagdány, M.³ Rabeh, W.M.⁴ Du, K.⁵ Höhfeld, J.⁶ Young, J.C.⁷ Lukacs, G.L.⁸

28
- 24644464284
- Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening
- Pedemonte, N., G.L. Lukacs, K. Du, E. Caci, O. Zegarra-Moran, L.J. Galietta, and A.S. Verkman. 2005a. Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115:2564-2571. http://dx.doi.org/10.1172/JCI24898
- (2005) J. Clin. Invest. , vol.115 , pp. 2564-2571
- Pedemonte, N.¹ Lukacs, G.L.² Du, K.³ Caci, E.⁴ Zegarra-Moran, O.⁵ Galietta, L.J.⁶ Verkman, A.S.⁷

29
- 20944442087
- Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating
- Pedemonte, N., N.D. Sonawane, A. Taddei, J. Hu, O. Zegarra-Moran, Y.F. Suen, L.I. Robins, C.W. Dicus, D. Willenbring, M.H. Nantz, et al. 2005b. Phenylglycine and sulfonamide correctors of defective delta F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating. Mol. Pharmacol. 67:1797-1807. http://dx.doi.org/10.1124/mol.105.010959
- (2005) Mol. Pharmacol. , vol.67 , pp. 1797-1807
- Pedemonte, N.¹ Sonawane, N.D.² Taddei, A.³ Hu, J.⁴ Zegarra-Moran, O.⁵ Suen, Y.F.⁶ Robins, L.I.⁷ Dicus, C.W.⁸ Willenbring, D.⁹ Nantz, M.H.¹⁰

30
- 77950204636
- Influence of cell background on pharmacological rescue of mutant CFTR
- Pedemonte, N., V. Tomati, E. Sondo, and L.J. Galietta. 2010. Influence of cell background on pharmacological rescue of mutant CFTR. Am. J. Physiol. Cell Physiol. 298:C866-C874. http://dx.doi.org/10.1152/ajpcell.00404.2009
- (2010) Am. J. Physiol. Cell Physiol. , vol.298
- Pedemonte, N.¹ Tomati, V.² Sondo, E.³ Galietta, L.J.⁴

31
- 77957302946
- Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1
- Protasevich, I., Z. Yang, C. Wang, S. Atwell, X. Zhao, S. Emtage, D. Wetmore, J.F. Hunt, and C.G. Brouillette. 2010. Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci. 19:1917-1931. http://dx.doi.org/10.1002/pro.479
- (2010) Protein Sci , vol.19 , pp. 1917-1931
- Protasevich, I.¹ Yang, Z.² Wang, C.³ Atwell, S.⁴ Zhao, X.⁵ Emtage, S.⁶ Wetmore, D.⁷ Hunt, J.F.⁸ Brouillette, C.G.⁹

32
- 84862908028
- Correction of both NBD1 energetics and domain interface is required to restore δF508 CFTR folding and function
- Rabeh, W.M., F. Bossard, H. Xu, T. Okiyoneda, M. Bagdany, C.M. Mulvihill, K. Du, S. di Bernardo, Y. Liu, L. Konermann, et al. 2012. Correction of both NBD1 energetics and domain interface is required to restore δF508 CFTR folding and function. Cell. 148:150-163. http://dx.doi.org/10.1016/j.cell.2011.11.024
- (2012) Cell , vol.148 , pp. 150-163
- Rabeh, W.M.¹ Bossard, F.² Xu, H.³ Okiyoneda, T.⁴ Bagdany, M.⁵ Mulvihill, C.M.⁶ Du, K.⁷ di Bernardo, S.⁸ Liu, Y.⁹ Konermann, L.¹⁰

33
- 80455162465
- A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
- VX08-770-102 Study Group
- Ramsey, B.W., J. Davies, N.G. McElvaney, E. Tullis, S.C. Bell, P. Dřevínek, M. Griese, E.F. McKone, C.E. Wainwright, M.W. Konstan, et al VX08-770-102 Study Group. 2011. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365:1663-1672. http://dx.doi.org/10.1056/NEJMoa1105185
- (2011) N. Engl. J. Med. , vol.365 , pp. 1663-1672
- Ramsey, B.W.¹ Davies, J.² McElvaney, N.G.³ Tullis, E.⁴ Bell, S.C.⁵ Dřevínek, P.⁶ Griese, M.⁷ McKone, E.F.⁸ Wainwright, C.E.⁹ Konstan, M.W.¹⁰

34
- 50649123290
- CFTR function and prospects for therapy
- Riordan, J.R. 2008. CFTR function and prospects for therapy. Annu. Rev. Biochem. 77:701-726. http://dx.doi.org/10.1146/annurev.biochem.75.103004.142532
- (2008) Annu. Rev. Biochem. , vol.77 , pp. 701-726
- Riordan, J.R.¹

35
- 0024424270
- Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA
- Riordan, J.R., J.M. Rommens, B. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J.L. Chou, et al. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 245:1066-1073. http://dx.doi.org/10.1126/science.2475911
- (1989) Science , vol.245 , pp. 1066-1073
- Riordan, J.R.¹ Rommens, J.M.² Kerem, B.³ Alon, N.⁴ Rozmahel, R.⁵ Grzelczak, Z.⁶ Zielenski, J.⁷ Lok, S.⁸ Plavsic, N.⁹ Chou, J.L.¹⁰

36
- 77952399647
- Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine
- Robert, R., G.W. Carlile, J. Liao, H. Balghi, P. Lesimple, N. Liu, B. Kus, D. Rotin, M. Wilke, H.R. de Jonge, et al. 2010. Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine. Mol. Pharmacol. 77:922-930. http://dx.doi.org/10.1124/mol.109.062679
- (2010) Mol. Pharmacol. , vol.77 , pp. 922-930
- Robert, R.¹ Carlile, G.W.² Liao, J.³ Balghi, H.⁴ Lesimple, P.⁵ Liu, N.⁶ Kus, B.⁷ Rotin, D.⁸ Wilke, M.⁹ de Jonge, H.R.¹⁰

37
- 52949154301
- Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs
- Rogers, C.S., D.A. Stoltz, D.K. Meyerholz, L.S. Ostedgaard, T. Rokhlina, P.J. Taft, M.P. Rogan, A.A. Pezzulo, P.H. Karp, O.A. Itani, et al. 2008. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science. 321:1837-1841. http://dx.doi.org/10.1126/science.1163600
- (2008) Science , vol.321 , pp. 1837-1841
- Rogers, C.S.¹ Stoltz, D.A.² Meyerholz, D.K.³ Ostedgaard, L.S.⁴ Rokhlina, T.⁵ Taft, P.J.⁶ Rogan, M.P.⁷ Pezzulo, A.A.⁸ Karp, P.H.⁹ Itani, O.A.¹⁰

38
- 0024453308
- Identification of the cystic fibrosis gene: chromosome walking and jumping
- Rommens, J.M., M.C. Iannuzzi, B. Kerem, M.L. Drumm, G. Melmer, M. Dean, R. Rozmahel, J.L. Cole, D. Kennedy, N. Hidaka, et al. 1989. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 245:1059-1065. http://dx.doi.org/10.1126/science.2772657
- (1989) Science , vol.245 , pp. 1059-1065
- Rommens, J.M.¹ Iannuzzi, M.C.² Kerem, B.³ Drumm, M.L.⁴ Melmer, G.⁵ Dean, M.⁶ Rozmahel, R.⁷ Cole, J.L.⁸ Kennedy, D.⁹ Hidaka, N.¹⁰

39
- 58149279835
- Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexindependent association of membrane spanning domain (MSD) 1 and MSD2
- Rosser, M.F., D.E. Grove, L. Chen, and D.M. Cyr. 2008. Assembly and misassembly of cystic fibrosis transmembrane conductance regulator: folding defects caused by deletion of F508 occur before and after the calnexindependent association of membrane spanning domain (MSD) 1 and MSD2. Mol. Biol. Cell. 19:4570-4579. http://dx.doi.org/10.1091/mbc.E08-04-0357
- (2008) Mol. Biol. Cell. , vol.19 , pp. 4570-4579
- Rosser, M.F.¹ Grove, D.E.² Chen, L.³ Cyr, D.M.⁴

40
- 35948979952
- Restoration of W1282X CFTR activity by enhanced expression
- Rowe, S.M., K. Varga, A. Rab, Z. Bebok, K. Byram, Y. Li, E.J. Sorscher, and J.P. Clancy. 2007. Restoration of W1282X CFTR activity by enhanced expression. Am. J. Respir. Cell Mol. Biol. 37:347-356. http://dx.doi.org/10.1165/rcmb.2006-0176OC
- (2007) Am. J. Respir. Cell Mol. Biol. , vol.37 , pp. 347-356
- Rowe, S.M.¹ Varga, K.² Rab, A.³ Bebok, Z.⁴ Byram, K.⁵ Li, Y.⁶ Sorscher, E.J.⁷ Clancy, J.P.⁸

41
- 79951829938
- Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR
- Sampson, H.M., R. Robert, J. Liao, E. Matthes, G.W. Carlile, J.W. Hanrahan, and D.Y. Thomas. 2011. Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. Chem. Biol. 18:231-242. http://dx.doi.org/10.1016/j.chembiol.2010.11.016
- (2011) Chem. Biol. , vol.18 , pp. 231-242
- Sampson, H.M.¹ Robert, R.² Liao, J.³ Matthes, E.⁴ Carlile, G.W.⁵ Hanrahan, J.W.⁶ Thomas, D.Y.⁷

42
- 0030042386
- Glycerol reverses the misfolding phenotype of the most common cystic fibrosismutation
- Sato, S., C.L. Ward, M.E. Krouse, J.J. Wine, and R.R. Kopito. 1996. Glycerol reverses the misfolding phenotype of the most common cystic fibrosismutation. J. Biol. Chem. 271:635-638. http://dx.doi.org/10.1074/jbc.271.2.635
- (1996) J. Biol. Chem. , vol.271 , pp. 635-638
- Sato, S.¹ Ward, C.L.² Krouse, M.E.³ Wine, J.J.⁴ Kopito, R.R.⁵

43
- 78349290383
- Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis
- Sermet-Gaudelus, I., K.D. Boeck, G.J. Casimir, F. Vermeulen, T. Leal, A. Mogenet, D. Roussel, J. Fritsch, L. Hanssens, S. Hirawat, et al. 2010. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis. Am. J. Respir. Crit. Care Med. 182:1262-1272. http://dx.doi.org/10.1164/rccm.201001-0137OC
- (2010) Am. J. Respir. Crit. Care Med. , vol.182 , pp. 1262-1272
- Sermet-Gaudelus, I.¹ Boeck, K.D.² Casimir, G.J.³ Vermeulen, F.⁴ Leal, T.⁵ Mogenet, A.⁶ Roussel, D.⁷ Fritsch, J.⁸ Hanssens, L.⁹ Hirawat, S.¹⁰

44
- 42149120706
- Phenylalanine-508 mediates a cytoplasmicmembrane domain contact in the CFTR 3D structure crucial to assembly and channel function
- Serohijos, A.W., T. Hegedus, A.A. Aleksandrov, L. He, L. Cui, N.V. Dokholyan, and J.R. Riordan. 2008. Phenylalanine-508 mediates a cytoplasmicmembrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc. Natl. Acad. Sci. USA. 105:3256-3261. http://dx.doi.org/10.1073/pnas.0800254105
- (2008) Proc. Natl. Acad. Sci. USA. , vol.105 , pp. 3256-3261
- Serohijos, A.W.¹ Hegedus, T.² Aleksandrov, A.A.³ He, L.⁴ Cui, L.⁵ Dokholyan, N.V.⁶ Riordan, J.R.⁷

45
- 0035937847
- Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments
- Sharma, M., M. Benharouga, W. Hu, and G.L. Lukacs. 2001. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J. Biol. Chem. 276:8942-8950. http://dx.doi.org/10.1074/jbc.M009172200
- (2001) J. Biol. Chem. , vol.276 , pp. 8942-8950
- Sharma, M.¹ Benharouga, M.² Hu, W.³ Lukacs, G.L.⁴

46
- 77956379893
- Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis
- Sun, X., H. Sui, J.T. Fisher, Z. Yan, X. Liu, H.J. Cho, N.S. Joo, Y. Zhang, W. Zhou, Y. Yi, et al. 2010. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 120:3149-3160. http://dx.doi.org/10.1172/JCI43052
- (2010) J. Clin. Invest. , vol.120 , pp. 3149-3160
- Sun, X.¹ Sui, H.² Fisher, J.T.³ Yan, Z.⁴ Liu, X.⁵ Cho, H.J.⁶ Joo, N.S.⁷ Zhang, Y.⁸ Zhou, W.⁹ Yi, Y.¹⁰

47
- 78149270037
- The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis
- Thibodeau, P.H., J.M. Richardson III, W. Wang, L. Millen, J. Watson, J.L. Mendoza, K. Du, S. Fischman, H. Senderowitz, G.L. Lukacs, et al. 2010. The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J. Biol. Chem. 285:35825-35835. http://dx.doi.org/10.1074/jbc.M110.131623
- (2010) J. Biol. Chem. , vol.285 , pp. 35825-35835
- Thibodeau, P.H.¹ Richardson III, J.M.² Wang, W.³ Millen, L.⁴ Watson, J.⁵ Mendoza, J.L.⁶ Du, K.⁷ Fischman, S.⁸ Senderowitz, H.⁹ Lukacs, G.L.¹⁰

48
- 33744831154
- Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
- Van Goor, F., K.S. Straley, D. Cao, J. González, S. Hadida, A. Hazlewood, J. Joubran, T. Knapp, L.R. Makings, M. Miller, et al. 2006. Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L1117-L1130. http://dx.doi.org/10.1152/ajplung.00169.2005
- (2006) Am. J. Physiol. Lung Cell. Mol. Physiol. , vol.290
- Van Goor, F.¹ Straley, K.S.² Cao, D.³ González, J.⁴ Hadida, S.⁵ Hazlewood, A.⁶ Joubran, J.⁷ Knapp, T.⁸ Makings, L.R.⁹ Miller, M.¹⁰

49
- 73249114731
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator
- Van Goor, F., S. Hadida, P.D. Grootenhuis, B. Burton, D. Cao, T. Neuberger, A. Turnbull, A. Singh, J. Joubran, A. Hazlewood, et al. 2009. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. USA. 106:18825-18830. http://dx.doi.org/10.1073/pnas.0904709106
- (2009) VX-770. Proc. Natl. Acad. Sci. USA. , vol.106 , pp. 18825-18830
- Van Goor, F.¹ Hadida, S.² Grootenhuis, P.D.³ Burton, B.⁴ Cao, D.⁵ Neuberger, T.⁶ Turnbull, A.⁷ Singh, A.⁸ Joubran, J.⁹ Hazlewood, A.¹⁰

50
- 81755163563
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- Van Goor, F., S. Hadida, P.D. Grootenhuis, B. Burton, J.H. Stack, K.S. Straley, C.J. Decker, M. Miller, J. McCartney, E.R. Olson, et al. 2011. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc. Natl. Acad. Sci. USA. 108:18843-18848. http://dx.doi.org/10.1073/pnas.1105787108
- (2011) Proc. Natl. Acad. Sci. USA. , vol.108 , pp. 18843-18848
- Van Goor, F.¹ Hadida, S.² Grootenhuis, P.D.³ Burton, B.⁴ Stack, J.H.⁵ Straley, K.S.⁶ Decker, C.J.⁷ Miller, M.⁸ McCartney, J.⁹ Olson, E.R.¹⁰

51
- 59349091561
- Chloride channels as drug targets
- Verkman, A.S., and L.J. Galietta. 2009. Chloride channels as drug targets. Nat. Rev. Drug Discov. 8:153-171. http://dx.doi.org/10.1038/nrd2780
- (2009) Nat. Rev. Drug Discov. , vol.8 , pp. 153-171
- Verkman, A.S.¹ Galietta, L.J.²

52
- 77957309337
- Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis
- Wang, C., I. Protasevich, Z. Yang, D. Seehausen, T. Skalak, X. Zhao, S. Atwell, J. Spencer Emtage, D.R. Wetmore, C.G. Brouillette, and J.F. Hunt. 2010. Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis. Protein Sci. 19:1932-1947. http://dx.doi.org/10.1002/pro.480
- (2010) Protein Sci , vol.19 , pp. 1932-1947
- Wang, C.¹ Protasevich, I.² Yang, Z.³ Seehausen, D.⁴ Skalak, T.⁵ Zhao, X.⁶ Atwell, S.⁷ Spencer Emtage, J.⁸ Wetmore, D.R.⁹ Brouillette, C.G.¹⁰ Hunt, J.F.¹¹

53
- 36348989763
- Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein
- Wang, Y., T.W. Loo, M.C. Bartlett, and D.M. Clarke. 2007. Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein. J. Biol. Chem. 282:33247-33251. http://dx.doi.org/10.1074/jbc.C700175200
- (2007) J. Biol. Chem. , vol.282 , pp. 33247-33251
- Wang, Y.¹ Loo, T.W.² Bartlett, M.C.³ Clarke, D.M.⁴

54
- 0028840915
- Degradation of CFTR by the ubiquitin-proteasome pathway
- Ward, C.L., S. Omura, and R.R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 83:121-127. http://dx.doi.org/10.1016/0092-8674(95)90240-6
- (1995) Cell , vol.83 , pp. 121-127
- Ward, C.L.¹ Omura, S.² Kopito, R.R.³

55
- 34247588271
- PTC124 targets genetic disorders caused by nonsense mutations
- Welch, E.M., E.R. Barton, J. Zhuo, Y. Tomizawa, W.J. Friesen, P. Trifillis, S. Paushkin, M. Patel, C.R. Trotta, S. Hwang, et al. 2007. PTC124 targets genetic disorders caused by nonsense mutations. Nature. 447:87-91. http://dx.doi.org/10.1038/nature05756
- (2007) Nature , vol.447 , pp. 87-91
- Welch, E.M.¹ Barton, E.R.² Zhuo, J.³ Tomizawa, Y.⁴ Friesen, W.J.⁵ Trifillis, P.⁶ Paushkin, S.⁷ Patel, M.⁸ Trotta, C.R.⁹ Hwang, S.¹⁰

56
- 0141863491
- Gentamicininduced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
- Wilschanski, M., Y. Yahav, Y. Yaacov, H. Blau, L. Bentur, J. Rivlin, M. Aviram, T. Bdolah-Abram, Z. Bebok, L. Shushi, et al. 2003. Gentamicininduced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N. Engl. J. Med. 349:1433-1441. http://dx.doi.org/10.1056/NEJMoa022170
- (2003) N. Engl. J. Med. , vol.349 , pp. 1433-1441
- Wilschanski, M.¹ Yahav, Y.² Yaacov, Y.³ Blau, H.⁴ Bentur, L.⁵ Rivlin, J.⁶ Aviram, M.⁷ Bdolah-Abram, T.⁸ Bebok, Z.⁹ Shushi, L.¹⁰

57
- 84862776940
- Ivacaftor potentiation of multiple CFTR channels with gating mutations
- Yu, H., B. Burton, C.J. Huang, J. Worley, D. Cao, J.P. Johnson Jr., A. Urrutia, J. Joubran, S. Seepersaud, K. Sussky, et al. 2012. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J. Cyst. Fibros. 11:237-245. http://dx.doi.org/10.1016/j.jcf.2011.12.005
- (2012) J. Cyst. Fibros. , vol.11 , pp. 237-245
- Yu, H.¹ Burton, B.² Huang, C.J.³ Worley, J.⁴ Cao, D.⁵ Johnson Jr, J.P.⁶ Urrutia, A.⁷ Joubran, J.⁸ Seepersaud, S.⁹ Sussky, K.¹⁰

58
- 0034109607
- Genotype and phenotype in cystic fibrosis
- Zielenski, J. 2000. Genotype and phenotype in cystic fibrosis. Respiration. 67:117-133. http://dx.doi.org/10.1159/000029497
- (2000) Respiration , vol.67 , pp. 117-133
- Zielenski, J.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.